Preferred Pharmaceuticals, Inc. recalls Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC: 68788-
Recalled July 12, 2023 · FDA recall D-0894-2023 · Preferred Pharmaceuticals
Hazard
Failed Stability Specifications · FDA Class II
Units
541 Bottles
Sold at
Nationwide within the United States
Description
Failed Stability Specifications
Product
Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC: 68788-7781-3), c) 60-count bottles, (NDC: 68788-7781-6), d) 90-count bottles (NDC: 68788-7781-9), e) 120-count bottles (NDC: 68788-7781-8), Rx only, Mfg: Dr. Reddy's Laboratories Limited.
Manufacturer(s)
Preferred Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →